- USP and EP both set WFI endotoxin limits around 0.25 EU/mL, but historically differed on permitted production methods, a gap that has narrowed as both pharmacopeias now accept validated membrane-based production alongside distillation.
- GMP compliance for WFI systems rests on USP <1231> life cycle validation, not just meeting the numeric limits on a single test day.
- Cross-market manufacturers need to design to the stricter of USP and EP requirements where they diverge, not pick whichever pharmacopeia is more convenient for a given production run.
What Does USP Require for WFI?
USP sets WFI conductivity at the same 1.3 µS/cm Stage 1 limit as Purified Water, adds an endotoxin limit around 0.25 EU/mL, and governs the validation and monitoring life cycle through General Chapter <1231>. The current USP monograph permits both distillation and validated membrane-based (RO) production methods, a change from the historically distillation-only requirement.
What Does EP Require for WFI?
EP historically required distillation specifically for WFI production, a stricter stance than USP’s evolving position on membrane-based methods, though EP has moved toward permitting validated non-distillation production as well following its own monograph revisions. EP also formally recognizes Highly Purified Water (HPW) as a distinct grade equivalent to WFI in chemical, microbial, and endotoxin terms, produced by membrane processes rather than distillation, a grade USP doesn’t separately monograph.
What Does GMP Compliance Require Beyond Numeric Limits?
Meeting the conductivity, TOC, and endotoxin numbers on a given test day doesn’t establish GMP compliance on its own. Compliance requires the full USP <1231> validation life cycle: design qualification, IQ/OQ/PQ, ongoing monitoring with documented trigger levels below the hard action limits, and periodic requalification whenever the system changes. Auditors look for sustained performance evidence, not a single passing result.
How Do You Design a WFI System for Multiple Markets?
Manufacturers selling into both USP and EP-governed markets generally need to design to whichever standard is stricter on a given parameter, rather than maintaining separate systems or switching compliance basis by production run. In practice this usually means validating against EP’s traditionally more conservative production method requirements while meeting both pharmacopeias’ numeric limits, since retrofitting a system to a stricter standard later is far more expensive than designing for it upfront.
Frequently Asked Questions
Are USP and EP endotoxin limits for WFI the same?
Both set WFI endotoxin limits around 0.25 EU/mL. The more significant historical difference was in permitted production methods, with EP traditionally more conservative about non-distillation production than USP.
Does EP recognize Highly Purified Water as equivalent to WFI?
Yes, EP defines HPW as chemically, microbially, and endotoxin-wise equivalent to WFI, produced via membrane processes. USP does not maintain a separate HPW monograph.
What does GMP compliance require beyond meeting numeric limits?
Full USP <1231> validation life cycle documentation: design qualification, IQ/OQ/PQ, ongoing monitoring with trigger levels, and periodic requalification whenever the system changes.
SKE & Eagle Multi-Standard WFI Systems
SKE & Eagle designs WFI systems validated to meet both USP and EP requirements for manufacturers serving multiple markets. See our WFI overview for production method details.